|
楼主 |
发表于 2013-7-29 06:23 PM
|
显示全部楼层
本帖最后由 wsjboy 于 2013-8-5 03:48 PM 编辑
PFE, heal,pfizer,drug manfctrrs-majr, in vil6_set sp500_set PFE yahoo finviz google fool
pe 19.98,peg 6.01,alpha 20.50,beta 0.73,a_vol 60277, div 3.27 130731,insi 0.1 1.05,inst 73.2 -0.5,
=====================
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer’s disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
=====================
,一家生物制药公司,辉瑞公司发现,开发,制造和销售世界各地的人与动物的药物。基层医疗分部提供人类处方药产品主要规定的初级保健医生为阿尔茨海默病,心血管疾病,勃起功能障碍,泌尿生殖系统,严重抑郁症,疼痛,呼吸,和戒烟治疗和疾病领域?该公司的专业护理和肿瘤分部为人类提供的处方药产品,抗感染,内分泌失调,血友病,炎症,眼科,肺动脉高血压,神经科学专业,和疫苗,以及肿瘤和肿瘤相关的疾病。其成熟产品和新兴市场分部提供人类处方药品失去专利保护或营销排他性的产品在某些国家和/或区域,以及被出售的新兴市场,包括亚洲,拉丁美洲,中东,东欧,非洲,土耳其和中欧。该公司的动物健康分部提供的产品和服务,牲畜和伴侣动物疾病预防和治疗,包括抗感染,疫苗,驱虫,药物饲料添加剂,其他医药产品,以及其他非医药产品。消费者保健业务提供非处方产品,如在治疗类膳食补充剂,疼痛管理,呼吸,及个人护理。本公司所销售的产品批发商,分销商,零售商,医院,诊所,政府机构,药店,个人提供办公室,兽医,家畜生产者,杂货店和便利店。辉瑞公司有战略合作与CytomX Therapeutics公司开发和商品化的多个Probody偶联药物肿瘤。该公司成立于1849年,总部设在纽约,纽约。
=====================
|
|